{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreigs3ovoime5ka737r2q372ctuudvgwyu42hv4dpv4yeqwyujg2yui",
    "uri": "at://did:plc:izotgtw5czjnuqtpcldjnkjh/app.bsky.feed.post/3mmfqk4utu5g2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreiadiqrglzx7qy53afqsanvdbe3n7krf5a4uuc63c2zq3cx5x2fxvu"
    },
    "mimeType": "image/jpeg",
    "size": 672289
  },
  "path": "/breakthrough-parkinsons-drug-targets-disease-at-its-genetic-roots/",
  "publishedAt": "2026-05-21T16:12:03.000Z",
  "site": "https://scitechdaily.com",
  "tags": [
    "Health",
    "Gene Therapy",
    "Neurology",
    "Neuroscience",
    "Northwestern University",
    "Parkinson's Disease"
  ],
  "textContent": "An experimental gene-silencing therapy safely lowered LRRK2 protein levels in an early Parkinson’s trial, but its effect on symptoms remains untested. An experimental medicine built to silence a gene closely associated with Parkinson’s disease has produced encouraging results in its first clinical test in people, according to a study published in Nature Medicine. The treatment, [...]",
  "title": "Breakthrough Parkinson’s Drug Targets Disease at Its Genetic Roots"
}